nifedipine has been researched along with 15-hydroxy-5,8,11,13-eicosatetraenoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herman, AG; Van Diest, MJ; Verbeuren, TJ | 1 |
| Bode, M; Drutkowski, G; Frohberg, P; Görlitzer, K | 1 |
2 other study(ies) available for nifedipine and 15-hydroxy-5,8,11,13-eicosatetraenoic acid
| Article | Year |
|---|---|
Cyclo-oxygenase blockers influence the effects of 15-lipoxygenase metabolites of arachidonic acid in isolated canine blood vessels.
Topics: Animals; Arachidonate 15-Lipoxygenase; Arachidonate Lipoxygenases; Arachidonic Acids; Aspirin; Cyclooxygenase Inhibitors; Dogs; Hydroxyeicosatetraenoic Acids; Indomethacin; Leukotrienes; Lipid Peroxides; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine | 1986 |
[Benzo[c][2,7]naphthyridines from 2,6-dinor-nifedipine and its dimethyl 2,5-dicarboxylate isomer].
Topics: Antimalarials; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Cyclization; Electrochemistry; Humans; Hydrochloric Acid; Hydroxamic Acids; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Indicators and Reagents; Isomerism; Lipoxygenase Inhibitors; Naphthyridines; Nifedipine; Oxidation-Reduction; Ultraviolet Rays; Zinc | 2004 |